ABX-4233

N/A

Report date: 2025/07/11 11:53:03

Base Information

Drug NameABX-4233

Drug Alias NameABX4233ABX-4233

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 3 agonistsAnti-V-set domain-containing T-cell activation inhibitor 1

TargetsTumor necrosis factor receptor superfamily member 3V-set domain-containing T-cell activation inhibitor 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNGM Biopharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesNGM Biopharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A